| 161 Oral, ultra–long-lasting drug delivery: Application toward malaria elimination goals.
160 Tilting the balance between RNA interference and replication eradicates Leishmania RNA virus 1 and mitigates the inflammatory response.
159 The effect of mass mosquito trapping on malaria transmission and disease burden (SolarMal).
158 Comparative genomics reveals adaptive evolution of Asian tapeworm in switching to a new intermediate host.
157 Efficacy of the Olyset Duo net against insecticide-resistant mosquito vectors of malaria.
156 A selective inhibitor of the kinetoplastid proteasome (GNF6702) is identified that is highly efficacious in vivo, clearing the parasites that cause leishmaniasis, Chagas disease and sleeping sickness from mice, highlighting the possibility of developing a single class of drugs for these neglected diseases.
155 Elimination of Taenia solium Transmission in Northern Peru.
154 A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.
153 Mammalian African trypanosome VSG coat enhances tsetse’s vector competence.
152 Ape malaria transmission and potential for ape-to-human transfers in Africa.